# EDGAR Filing Document

**Accession Number:** 0001611746
**File Stem:** 0001213900-26-007705
**Filing Date:** 2026-1
**Character Count:** 23086
**Document Hash:** 58f4c8a493b083f03817e27b570346cf
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-007705.hdr.sgml**: 20260126

**ACCESSION NUMBER**: 0001213900-26-007705

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20260126

**DATE AS OF CHANGE**: 20260126

**EFFECTIVENESS DATE**: 20260126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SciSparc Ltd.
- **CENTRAL INDEX KEY:** 0001611746
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292952
- **FILM NUMBER:** 26560564

**BUSINESS ADDRESS:**
- **STREET 1:** 20 RAUL WALLENBERG STREET, TOWER A
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6971916
- **BUSINESS PHONE:** 972-3-6103100

**MAIL ADDRESS:**
- **STREET 1:** 20 RAUL WALLENBERG STREET, TOWER A
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6971916

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SciSparc Ltd./ADR
- **DATE OF NAME CHANGE:** 20210129

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Therapix Biosciences Ltd.
- **DATE OF NAME CHANGE:** 20140624

**As filed with the Securities and Exchange Commission on January 26, 2026**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

***UNDER***

***THE SECURITIES ACT OF 1933***

**SCISPARC LTD.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **State of Israel** | **Not applicable** |
| **(State or other jurisdiction of<br> incorporation or organization)** | **(I.R.S. Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **20 Raul Wallenberg Street, Tower A<br> Tel Aviv, Israel** | **6971916** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**SciSparc Ltd. 2023 Share Incentive Plan**

**(Full title of the plan)**

**Puglisi & Associates**

**850 Library Ave., Suite 204**

**Newark, DE 19711**

**Tel: (302) 738-6680**

**(Name, address, including zip code, and telephone number, including area code, of agent for service)**

***Copies to:***

---

| | |
|:---|:---|
| **Shachar Hadar<br> Meitar \| Law Offices<br> 16 Abba Hillel Road<br> Ramat Gan, 5250608, Israel<br> Tel: +972 (3) 610-3100** | **Oded Har-Even, Esq.**<br> **Howard Berkenblit, Esq.**<br> **Sullivan & Worcester LLP**<br> **1251 Avenue of the Americas**<br> **New York, NY 10020**<br> **(212)-660-3000** |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☐ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

This Registration Statement is being filed to register an additional 984,810 ordinary shares, no par value (the "**Ordinary Shares**"), of SciSparc Ltd. (the "**Registrant**," "**we**," "**our**" or "**us**") issuable pursuant to the SciSparc Ltd. 2023 Share Incentive Plan (the "**2023 Plan**").

On April 1, 2024, we filed with the Securities and Exchange Commission (the "**Commission**") a registration statement on [Form S-8](http://www.sec.gov/Archives/edgar/data/1611746/000121390024028880/ea0203015-s8_scisparc.htm) (File No. 333-278437) registering 48,276 Ordinary Shares (as adjusted for the reverse share split of the Ordinary Shares at the ratio of 1-to-21, effective as of July 3, 2025) issuable under the 2023 Plan. On April 28, 2025, we filed with the Commission an additional registration statement on [Form S-8](http://www.sec.gov/Archives/edgar/data/1611746/000121390025035801/ea0239224-s8_scisparc.htm) (File No. 333-286791), to register an additional 47,619 Ordinary Shares (as adjusted for the reverse share split of the Ordinary Shares at the ratio of 1-to-21, effective as of July 3, 2025) under the 2023 Plan.

Pursuant to Instruction E of Form S-8, the contents of our prior registration statements on Form S-8 (File Nos. [333-278437](http://www.sec.gov/Archives/edgar/data/1611746/000121390024028880/ea0203015-s8_scisparc.htm) and [333-286791](http://www.sec.gov/Archives/edgar/data/1611746/000121390025035801/ea0239224-s8_scisparc.htm)) are incorporated herein by reference, and the information required by Part II is omitted, except as supplemented by the information set forth below.

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS**

The documents containing the information required in Part I of this Registration Statement have been or will be sent or given to participating employees as specified in Rule 428(b)(1) under the Securities Act of 1933, as amended, or the Securities Act, in accordance with the rules and regulations of the Commission. Such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 of the Securities Act. These documents and the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the Plan covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended.

**PART II**

**Information Required in the Registration Statement**

**Item 3**. **Incorporation of Documents by Reference.**

We hereby incorporate by reference the following documents (or portions thereof) that we have filed with or furnished to the Commission:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Our Annual Report on [Form 20-F](http://www.sec.gov/Archives/edgar/data/1611746/000121390025035115/ea0237489-20f_scisparc.htm) for the year ended December 31, 2024, filed with the Commission on April 24, 2025
(File No. 001-38041) (the "**Annual Report** ");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
Registrant's Reports on Form 6-K filed with the Commission on [April 25, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025035257/ea0239544-6k_scisparc.htm) , [May 13, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025042248/ea0241708-6k_scisparc.htm) , [May 21, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025046434/ea0243053-6k_scisparc.htm) , [May 27, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025047791/ea0243470-6k_scisparc.htm) (with respect to the first two paragraphs and the section titled "Forward-Looking Statements" in the press release
attached as Exhibit 99.1), [June 9, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025052608/ea0244948-6k_scisparc.htm) , [June 24, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025057295/ea024677302-6k_scisparc.htm) , [June 25, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025057499/ea0246899-6k_scisparcltd.htm) , [June 26, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025058382/ea0247133-6k_scisparc.htm) , [July 22, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025066626/ea0249828-6k_scisparc.htm) , [July 22, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025066350/ea0249827-6k_scisparc.htm) , [July 31, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025069979/ea0250762-6k_scisparc.htm) , [August 8, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025073278/ea0252216-6k_scisparc.htm) , [August 25, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025080337/ea0254471-6k_scisparc.htm) , [August 26, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025080737/ea0254681-6k_scisparc.htm) , [August 28, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025081731/ea0254941-6k_scisparc.htm) , [August 29, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025082068/ea0255213-6k_scisparc.htm) , [September 16, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025088197/ea0257579-6k_scisparc.htm) , [September 25, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025091658/ea0258761-6k_scisparc.htm) , [September 26, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025091972/ea0258926-6k_scisparc.htm) , [September 30, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025093386/ea0259447-6k_scisparc.htm) , [October 6, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025096287/ea0260366-6k_scisparc.htm) , [October 15, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025099227/ea0261362-6k_scisparc.htm) , [October 20, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025100182/ea0261782-6k_scisparc.htm) , [October 24, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025102142/ea0262426-6k_scisparc.htm) ; [October 27, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025102348/ea0262584-6k_scisparc.htm) , [November, 18, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025112079/ea0263084-6k_scisparc.htm) , [November 20, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025112861/ea0266570-6k_scisparc.htm) , [November 26, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025115471/ea0267400-6k_scisparc.htm) , [November 28, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025115749/ea0267637-6k_scisparc.htm) , [December 2, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025117229/ea0268087-6k_scisparc.htm) , [December 31, 2025](http://www.sec.gov/Archives/edgar/data/1611746/000121390025126819/ea0269021-6k_scisparc.htm) , [January 12, 2026](http://www.sec.gov/Archives/edgar/data/1611746/000121390026003395/ea0272617-6k_scisparc.htm) , [January 13, 2026](http://www.sec.gov/Archives/edgar/data/1611746/000121390026003668/ea0272536-6k_scisparc.htm) , [January 13, 2026](http://www.sec.gov/Archives/edgar/data/1611746/000121390026003694/ea0272695-6k_scisparc.htm) , and [January 26, 2026](https://www.sec.gov/Archives/edgar/data/1611746/000121390026007693/ea0274066-6k_scisparc.htm) , and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The description of our securities
contained in our [Form 8-A](http://www.sec.gov/Archives/edgar/data/1611746/000121390021066377/ea151944-8a12b_scisparc.htm) filed on December 20, 2021 (File No. 001-38041), including as amended by Exhibit 2.1
to the Annual Report and any further amendment or report filed for the purpose of updating such description.

All other documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, and, to the extent designated therein, Reports of Foreign Private Issuer on Form 6-K furnished by us to the Commission that are identified in such forms as being incorporated into this Registration Statement, in each case, subsequent to the effective date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement indicating that all securities offered under the Registration Statement have been sold, or deregistering all securities then remaining unsold, are also incorporated herein by reference and shall be a part hereof from the date of the filing or furnishing of such documents.

Any statement contained herein or in a document all or a portion of which is incorporated or deemed incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 8. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Exhibit** |
| 4.1 | [Amended and Restated Articles of Association of the Registrant (1)](http://www.sec.gov/Archives/edgar/data/1611746/000121390025058382/ea024713301ex99-1_scisparc.htm) |
| 5.1\* | [Opinion of Meitar \\| Law Offices as to the legality of the Registrant's Ordinary Shares](ea027370801ex5-1_scisparc.htm) |
| 23.1\* | [Consent of Kost, Forer, Gabbay and Kasierer, a member of EY Global](ea027370801ex23-1_scisparc.htm) |
| 23.2\* | [Consent of Meitar \\| Law Offices (included in Exhibit 5.1)](ea027370801ex5-1_scisparc.htm) |
| 24.1\* | [Power of Attorney (included on the signature page of this Registration Statement)](#p_001) |
| 99.1 | [SciSparc Ltd. 2023 Share Incentive Plan (2)](http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391ex10-7_scisparcltd.htm) |
| 107.1\* | [Filing Fee Table](ea027370801ex-fee_scisparc.htm) |

---

(1) Incorporated by reference to Exhibit
99.1 to the Registrant's Report on Form 6-K, furnished with the Commission on June 26, 2025.

(2) Incorporated by reference to Exhibit
10.7 to the Registrant's Registration Statement on Form F-1 (File No. 333-277394), filed with the Commission on February 27, 2024.

\* Filed herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the United States, on this 26<sup>th</sup> day of January, 2026.

---

| | |
|:---|:---|
| **SCISPARC LTD.** | **SCISPARC LTD.** |
| By: | /s/ Oz Adler |
| Name: | Oz Adler |
| Title: | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below hereby constitutes and appoints Oz Adler, his or her true and lawful attorney-in-fact and agent, with full power to act separately and full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto the said attorney-in-fact and agent full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Oz Adler | Chief Executive Officer and Chief Financial Officer | January 26, 2026 |
| Oz Adler | (Principal Executive Officer and Principal Accounting Officer) |  |
| /s/ Itschak Shrem | Chairman of the Board of Directors | January 26, 2026 |
| Itschak Shrem |  |  |
| /s/ Amnon Ben Shay | Director | January 26, 2026 |
| Amnon Ben Shay |  |  |
| /s/ Alon Dayan | Director | January 26, 2026 |
| Alon Dayan |  |  |
| /s/ Moshe Revach | Director | January 26, 2026 |
| Moshe Revach |  |  |
| /s/ Liat Sidi | Director | January 26, 2026 |
| Liat Sidi |  |  |
| /s/ Lior Vider | Director | January 26, 2026 |
| Lior Vider |  |  |
| <br> /s/ Amitay Weiss | Director | January 26, 2026 |
| Amitay Weiss |  |  |

---

**<u>AUTHORIZED REPRESENTATIVE:</u>**

Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of SciSparc Ltd. has signed this registration statement on January 26, 2026.

**PUGLISIGI & ASSOCIATES**

---

| | |
|:---|:---|
| By: | /s/ Donald J. Puglisi |
| Name: | Donald J. Puglisi |
| Title: | Managing Director |

---

## Exhibit 5.1

**Exhibit 5.1**

![](ex5-1_001.jpg)

January 26, 2026

SciSparc Ltd.<br> 20 Raul Wallenberg Street, Tower A, <br> Tel Aviv 6971916 Israel

**RE: <u>Registration on Form S-8</u>**

Ladies and Gentlemen:

We have acted as Israeli counsel to SciSparc Ltd., an Israeli company (the "**Company**"), in connection with its filing of a registration statement on Form S-8 on or about January 26, 2026 (the "**Registration Statement**"), under the Securities Act of 1933, as amended (the "**Securities Act**"), relating to the registration of an additional 984,810 ordinary shares, no par value ("**Ordinary Shares**"), of the Company which may be issued under the Scisparc Ltd. 2023 Share Incentive Plan (the "**2023 Plan**").

In our capacity as counsel to the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the Company's (i) amended and restated articles of association (the "**Articles**"), (ii) the 2023 Plan, (iii) resolutions of the Company's board of directors and (iv) other statements of corporate officers and other representatives of the Company and other documents provided to us by the Company as we have deemed necessary or appropriate as a basis for this opinion. In such examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals and the conformity with the original documents of all documents submitted to us as copies or facsimiles. As to any facts material to this opinion, to the extent that we did not independently establish relevant facts, we have relied on certificates of public officials and certificates of officers or other representatives of the Company. We have also assumed the truth of all facts communicated to us by the Company and that all consents, minutes and protocols of meetings of the Company's board of directors, which have been provided to us, are true and accurate and prepared in accordance with the Articles and all applicable laws. In addition, we have assumed that the Company will receive the full consideration for the Ordinary Shares (which may consist, in part or in full, of services performed for the Company).

We are admitted to practice law in the State of Israel and the opinion expressed herein is expressly limited to the laws of the State of Israel.

On the basis of the foregoing, we are of the opinion that the Ordinary Shares being registered pursuant to the Registration Statement, when issued and paid for in accordance with the 2023 Plan, pursuant to agreements with respect to the 2023 Plan and, as the case may be, pursuant to the terms of the awards that have been or may be granted under the 2023 Plan, will be validly issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this opinion and such consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act, the rules and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation S-K promulgated under the Securities Act.

This opinion letter is rendered as of the date hereof and we disclaim any obligation to advise you of facts, circumstances, events or developments that may be brought to our attention after the effective date of the Registration Statement that may alter, affect or modify the opinions expressed herein.

---

| |
|:---|
| Very truly yours, |
| */s/ Meitar \| Law Offices* |
| Meitar Law \| Offices |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in the Registration Statement (Form S-8)pertaining to the 2023 Share Incentive Plan of SciSparc Ltd. of our report dated April 24, 2025 (except for Note 1(d), as to which the date is July 8, 2025), with respect to the consolidated financial statements of SciSparc Ltd., included in the Report of Foreign Private Issuer on Form 6-K dated July 22, 2025 filed by SciSparc Ltd. with the Securities and Exchange Commission.

---

| | |
|:---|:---|
| January 26, 2026 | /s/ Kost Forer Gabbay & Kasierer |
| Tel Aviv, Israel | A Member of EY Global |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**S-8**

**SciSparc Ltd.**

**Table 1: Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Ordinary shares, no par value per share | (1) | Other | 984810 | $0.9850 | $970037.85 | 0.0001381 | $133.96 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $970037.85 |  | 133.96 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $133.96 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional ordinary shares that become issuable under the SciSparc Ltd. 2023 Share Incentive Plan (the "2023 Plan") by reason of any share dividend, share split, recapitalization, or any other similar transaction without receipt of consideration which results in an increase in the number of outstanding ordinary shares. Pursuant to Rule 457(c) of the Securities Act, the Proposed Maximum Offering Price Per Share with respect to the 2023 Plan is based upon the average of the high and low prices of the Registrant's ordinary shares, as reported on the Nasdaq Capital Market on January 23, 2026, which date is within five business days prior to the filing of this Registration Statement.